Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study

被引：0
|
作者：
Zanetta, Chiara [1 ]
Rocca, Maria [2 ]
Meani, Alessandro [2 ]
Preziosa, Paolo [2 ,4 ,5 ,6 ]
Martinelli, Vittorio [1 ]
Ferre, Laura [1 ]
Moiola, Lucia [1 ]
Filippi, Massimo [3 ,4 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] IRCCS San Raffaele Sci, Div Neurosci, Neuroimaging Res Unit, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Neuroimaging Res Unit, Div Neurosci, Neurol Unit,Neurorehabil Unit, Milan, Italy
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Neuroimaging Res Unit, Div Neurosci, Milan, Italy
[6] IRCCS San Raffaele Sci Inst, Milan, Italy
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202398
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P8-3.015
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study
    Zanetta, Chiara
    Rocca, Maria A.
    Meani, Alessandro
    Martinelli, Vittorio
    Ferre, Laura
    Moiola, Lucia
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2023, 270 (07) : 3553 - 3564
  • [2] Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
    Chiara Zanetta
    Maria A. Rocca
    Alessandro Meani
    Vittorio Martinelli
    Laura Ferrè
    Lucia Moiola
    Massimo Filippi
    Journal of Neurology, 2023, 270 : 3553 - 3564
  • [3] Efficacy/safety profile of cladribine in an italian real-life cohort of relapsing remitting multiple sclerosis patients
    Zanetta, C.
    Sangalli, F.
    Guerrieri, S.
    Filippi, M.
    Montini, F.
    Moiola, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 325 - 325
  • [4] Efficacy and safety of natalizumab in relapsing-remitting multiple sclerosis: an Italian multicentre observational study
    Bucello, S.
    Sangalli, F.
    Moiola, L.
    Annovazzi, P.
    Rizzo, A.
    Radaelli, M.
    Ghezzi, A.
    Grimaldi, L.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S129 - S130
  • [5] Effectiveness of cladribine tablets in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
    Habek, M.
    Brecl, G. Jakob
    Rajda, C.
    Adamec, I.
    Barun, B.
    Rok, A.
    Ledinek, A. Horvat
    Rot, U.
    Jazbec, S. Sega
    Gabelic, T.
    Klivenyi, P.
    Skoric, M. Krbot
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 894 - 894
  • [6] Real-World Efficacy and Safety of Oral Cladribine in Korean Patients with Relapsing-Remitting Multiple Sclerosis
    Kim, Su-Hyun
    Kim, Ho Jin
    Kim, Sung Min
    Shin, Ha Young
    Kwon, Young Nam
    Nam, Tai-Seung
    Kim, Byoung Joon
    Min, Ju-Hong
    Kim, Jun Soon
    Su, Park Min
    Kim, Nam-Hee
    Shin, Jin-Hong
    Park, Young Eun
    Lim, Young-Min
    Lee, Eun-Jae
    Kim, Woojun
    Shon, Eun Hee
    Lee, Tae-Kyeong
    Taha, Karim
    Seo, Beom-Jun
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1099
  • [7] Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Adeniji, Abidemi K.
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1594 - 1604
  • [8] Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
    Yamout, Bassem I.
    Shatila, Ahmad
    Inshasi, Jihad
    Hassan, Ali Mohammed Ali
    Szolics, Mikolas
    Hassan, Ahmed
    Farw, Ahmed
    Ismail, Ghida
    Zeineddine, Maya
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 379 - 379
  • [9] Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study
    Achiron, Anat
    Warszawer, Yehuda
    Nissan, Yael
    Kerpel, Ariel
    Hoffmann, Chen
    Harari, Gil
    Magalashvili, David
    Tal, Sigal
    MULTIPLE SCLEROSIS JOURNAL, 2025,
  • [10] A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
    Moreau, T.
    Brudon, F.
    Debouverie, M.
    Heinzlef, O.
    Lebrun-Frenay, C.
    Gury, C.
    MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
12345